Avecho Biotechnology Limited
AVEFF
$0.0045
-$0.0129-74.14%
OTC PK
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 897.30K | 820.80K | 747.80K | 489.30K | 223.30K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 897.30K | 820.80K | 747.80K | 489.30K | 223.30K |
| Cost of Revenue | 339.80K | 321.50K | 304.20K | 315.10K | 323.30K |
| Gross Profit | 557.50K | 499.30K | 443.50K | 174.20K | -100.00K |
| SG&A Expenses | 1.66M | 1.50M | 1.34M | 1.28M | 1.22M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 3.14M | 2.95M | 2.77M | 2.64M | 2.50M |
| Operating Income | -2.24M | -2.12M | -2.02M | -2.15M | -2.28M |
| Income Before Tax | -2.32M | -2.18M | -2.06M | -2.18M | -2.29M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -2.32 | -2.18 | -2.06 | -2.18 | -2.29 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -2.32M | -2.18M | -2.06M | -2.18M | -2.29M |
| EBIT | -2.24M | -2.12M | -2.02M | -2.15M | -2.28M |
| EBITDA | -2.15M | -2.03M | -1.92M | -2.06M | -2.18M |
| EPS Basic | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 12.68B | 12.68B | 12.68B | 12.11B | 11.55B |
| Average Diluted Shares Outstanding | 12.68B | 12.68B | 12.68B | 12.11B | 11.55B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |